Ciclopirox olamine sensitizes leukemia cells to natural killer cell-mediated cytolysis by upregulating NKG2DLs via the Akt signaling pathway

Biochem Biophys Res Commun. 2023 Jun 4:659:10-19. doi: 10.1016/j.bbrc.2023.03.062. Epub 2023 Apr 1.

Abstract

The activating receptor natural killer group 2D (NKG2D) expressed by Natural killer (NK) cells functions as a "master-switch" in governing the awakening status of NK cells. The NKG2D-mediated cytotoxicity has been declared to be related with the expression levels of NKG2D ligands (NKG2DLs) expressed on tumor cells. Therefore, selective induction of NKG2DLs could be a reliable approach to enhance the efficacy of NK cell-mediated immunotherapy. Our existing study demonstrated that Ciclopirox Olamine (CPX), an off-patent antifungal agent, effectively elevated the expression of NKG2DLs on leukemia cells and sensitized leukemia cells to NK-cell mediated cytolysis. Induction of ROS production and AKT phosphorylation by CPX is essential for the up-regulation of NKG2DLs expressions. Inhibition of AKT by using AKT inhibitor MK2206 decreased both NKG2DLs expressions and NK cell cytotoxicity. These data indicated that increased sensitivity of CPX-treated leukemia cells to NK cell cytolysis was attributed to higher NKG2DLs expressions, resulting from activated AKT signaling pathway. Our findings support the ongoing development of CPX as an anti-tumor agent and suggest its promising immunotherapeutic value in the medication of leukemia.

Keywords: Ciclopirox olamine; Immunotherapy; NKG2D ligands; Natural killer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Ciclopirox / metabolism
  • Ciclopirox / pharmacology
  • Humans
  • Killer Cells, Natural / metabolism
  • Leukemia* / drug therapy
  • Leukemia* / metabolism
  • NK Cell Lectin-Like Receptor Subfamily K / metabolism
  • Proto-Oncogene Proteins c-akt* / metabolism
  • Signal Transduction

Substances

  • Proto-Oncogene Proteins c-akt
  • Ciclopirox
  • NK Cell Lectin-Like Receptor Subfamily K